Clinical Trials Directory

Trials / Conditions / High-risk Prostate Cancer

High-risk Prostate Cancer

26 registered clinical trials studyying High-risk Prostate Cancer — 14 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate
NCT07189598
Center Eugene MarquisN/A
RecruitingA Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
NCT06888102
Edwin Posadas, MDEARLY_Phase 1
RecruitingNeoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratifie
NCT07027124
Icahn School of Medicine at Mount SinaiPhase 2
Not Yet RecruitingAndrogen-responsive POSLUMA-guided Intra-prostatic Boost
NCT07393867
Martin T. King, MD, PhDPhase 2
Active Not RecruitingCOMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097
Heinrich-Heine University, Duesseldorf—
RecruitingTb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - Tbef
NCT07208240
Rabin Medical CenterPhase 1 / Phase 2
RecruitingComparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
NCT07054346
Thomas HopePhase 1
Not Yet RecruitingImmunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk P
NCT06765954
ImmunityBio, Inc.Phase 2
Not Yet RecruitingImmunotherapy Before and After Surgery
NCT06765902
ImmunityBio, Inc.Phase 2
RecruitingPRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for O
NCT06949254
Istituto Clinico Humanitas—
RecruitingDelayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer.
NCT07357259
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/A
RecruitingSurgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates f
NCT06758882
Marco OderdaPhase 2
RecruitingFK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
NCT06636682
Cellvax Therapeutics IncPhase 2
RecruitingA Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetat
NCT05593497
VA Office of Research and DevelopmentPhase 2
UnknownContribution of Canine Detection in the Diagnostic Strategy of High-risk Prostate Cancer (Prostate-K9-Detect)
NCT05558735
Assistance Publique - Hôpitaux de Paris—
UnknownFluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial
NCT05223582
Fudan UniversityPhase 2
RecruitingNeoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
NCT05406999
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2
UnknownPhase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
NCT03541928
The Methodist Hospital Research InstitutePhase 2
CompletedNovel Imaging in Staging of Primary Prostate Cancer
NCT03537391
Turku University HospitalN/A
CompletedGa-68-PSMA-11 in High-risk Prostate Cancer
NCT03362359
German Cancer Research CenterPhase 1 / Phase 2
UnknownPROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.
NCT03340272
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia—
CompletedEnzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
NCT02268175
Dana-Farber Cancer InstitutePhase 2
UnknownStereotactic Pelvic Brachytherapy With HDR Boost for Dose Escalation in High Tier Intermediate and High Risk P
NCT04236752
Sunnybrook Health Sciences CentreN/A
TerminatedNeoadjuvant BKM120 in High-risk Prostate Cancer
NCT01695473
Won KimPhase 2
TerminatedConventional Versus Hypofractionated Radiation in High Risk Prostate Patients
NCT01488968
AHS Cancer Control AlbertaN/A
CompletedHypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prosta
NCT02107287
Sergio FariaN/A